nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—prostate cancer—bone cancer	0.4	1	CtDrD
Cabazitaxel—TUBB4B—bone cancer	0.202	0.516	CbGaD
Cabazitaxel—TUBB2A—bone cancer	0.168	0.428	CbGaD
Cabazitaxel—CYP3A4—bone cancer	0.0219	0.056	CbGaD
Cabazitaxel—SLCO1B3—Methotrexate—bone cancer	0.0207	0.21	CbGbCtD
Cabazitaxel—ABCG2—Carboplatin—bone cancer	0.0172	0.175	CbGbCtD
Cabazitaxel—ABCG2—Cisplatin—bone cancer	0.0147	0.149	CbGbCtD
Cabazitaxel—SLCO1B1—Methotrexate—bone cancer	0.012	0.122	CbGbCtD
Cabazitaxel—ABCG2—Doxorubicin—bone cancer	0.00987	0.1	CbGbCtD
Cabazitaxel—ABCG2—Methotrexate—bone cancer	0.00956	0.097	CbGbCtD
Cabazitaxel—ABCB1—Cisplatin—bone cancer	0.00531	0.0539	CbGbCtD
Cabazitaxel—ABCB1—Doxorubicin—bone cancer	0.00356	0.0361	CbGbCtD
Cabazitaxel—ABCB1—Methotrexate—bone cancer	0.00345	0.035	CbGbCtD
Cabazitaxel—CYP3A4—Doxorubicin—bone cancer	0.00213	0.0216	CbGbCtD
Cabazitaxel—Paclitaxel—TUBB4B—bone cancer	0.000748	0.19	CrCbGaD
Cabazitaxel—Docetaxel—TUBB4B—bone cancer	0.000748	0.19	CrCbGaD
Cabazitaxel—Docetaxel—TUBB2A—bone cancer	0.00062	0.157	CrCbGaD
Cabazitaxel—Paclitaxel—TUBB2A—bone cancer	0.00062	0.157	CrCbGaD
Cabazitaxel—Paclitaxel—NR1I2—bone cancer	0.00041	0.104	CrCbGaD
Cabazitaxel—Docetaxel—NR1I2—bone cancer	0.00041	0.104	CrCbGaD
Cabazitaxel—Docetaxel—EGFR—bone cancer	0.000222	0.0564	CrCbGaD
Cabazitaxel—TUBB4A—Orphan transporters—TUBB4B—bone cancer	0.000162	0.00234	CbGpPWpGaD
Cabazitaxel—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000156	0.00226	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.000156	0.00226	CbGpPWpGaD
Cabazitaxel—TUBB1—Orphan transporters—TUBB2A—bone cancer	0.000156	0.00225	CbGpPWpGaD
Cabazitaxel—TUBA4A—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.000155	0.00225	CbGpPWpGaD
Cabazitaxel—TUBB4A—G2/M Transition—TUBB4B—bone cancer	0.000152	0.00219	CbGpPWpGaD
Cabazitaxel—TUBB4A—Mitotic G2-G2/M phases—TUBB4B—bone cancer	0.00015	0.00216	CbGpPWpGaD
Cabazitaxel—TUBB3—Diurnally Regulated Genes with Circadian Orthologs—GSTP1—bone cancer	0.000144	0.00208	CbGpPWpGaD
Cabazitaxel—CYP3A5—Irinotecan Pathway—CYP3A4—bone cancer	0.000141	0.00205	CbGpPWpGaD
Cabazitaxel—TUBB4A—Orphan transporters—TUBB2A—bone cancer	0.00014	0.00202	CbGpPWpGaD
Cabazitaxel—TUBB4B—Orphan transporters—TUBB2A—bone cancer	0.000128	0.00185	CbGpPWpGaD
Cabazitaxel—ABCG2—Fluoropyrimidine Activity—DHFR—bone cancer	0.000117	0.0017	CbGpPWpGaD
Cabazitaxel—CYP3A5—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000111	0.0016	CbGpPWpGaD
Cabazitaxel—CYP3A5—Xenobiotics—CYP3A4—bone cancer	0.000106	0.00154	CbGpPWpGaD
Cabazitaxel—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000102	0.00148	CbGpPWpGaD
Cabazitaxel—CYP3A5—Tamoxifen metabolism—CYP3A4—bone cancer	0.000102	0.00148	CbGpPWpGaD
Cabazitaxel—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	9.64e-05	0.00139	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metapathway biotransformation—CYP4V2—bone cancer	9.48e-05	0.00137	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—MOGS—bone cancer	9.32e-05	0.00135	CbGpPWpGaD
Cabazitaxel—CYP2C8—Xenobiotics—CYP3A4—bone cancer	9.21e-05	0.00133	CbGpPWpGaD
Cabazitaxel—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	9.14e-05	0.00132	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—ZW10—bone cancer	9.04e-05	0.00131	CbGpPWpGaD
Cabazitaxel—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	8.98e-05	0.0013	CbGpPWpGaD
Cabazitaxel—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	8.86e-05	0.00128	CbGpPWpGaD
Cabazitaxel—Hypokalaemia—Epirubicin—bone cancer	8.7e-05	0.0024	CcSEcCtD
Cabazitaxel—Breast disorder—Epirubicin—bone cancer	8.64e-05	0.00239	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Epirubicin—bone cancer	8.61e-05	0.00238	CcSEcCtD
Cabazitaxel—Hypotension—Cisplatin—bone cancer	8.55e-05	0.00236	CcSEcCtD
Cabazitaxel—Gastritis—Epirubicin—bone cancer	8.46e-05	0.00234	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Epirubicin—bone cancer	8.43e-05	0.00233	CcSEcCtD
Cabazitaxel—Cardiac arrest—Doxorubicin—bone cancer	8.41e-05	0.00232	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Cisplatin—bone cancer	8.34e-05	0.0023	CcSEcCtD
Cabazitaxel—Abdominal distension—Epirubicin—bone cancer	8.32e-05	0.0023	CcSEcCtD
Cabazitaxel—Influenza—Epirubicin—bone cancer	8.26e-05	0.00228	CcSEcCtD
Cabazitaxel—Dysuria—Methotrexate—bone cancer	8.26e-05	0.00228	CcSEcCtD
Cabazitaxel—Neutropenia—Methotrexate—bone cancer	8.26e-05	0.00228	CcSEcCtD
Cabazitaxel—Dehydration—Doxorubicin—bone cancer	8.23e-05	0.00227	CcSEcCtD
Cabazitaxel—Paraesthesia—Cisplatin—bone cancer	8.22e-05	0.00227	CcSEcCtD
Cabazitaxel—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	8.21e-05	0.00119	CbGpPWpGaD
Cabazitaxel—Upper respiratory tract infection—Methotrexate—bone cancer	8.21e-05	0.00227	CcSEcCtD
Cabazitaxel—Dyspnoea—Cisplatin—bone cancer	8.16e-05	0.00225	CcSEcCtD
Cabazitaxel—Paclitaxel—CYP3A4—bone cancer	8.11e-05	0.0206	CrCbGaD
Cabazitaxel—Docetaxel—CYP3A4—bone cancer	8.11e-05	0.0206	CrCbGaD
Cabazitaxel—Dry skin—Doxorubicin—bone cancer	8.11e-05	0.00224	CcSEcCtD
Cabazitaxel—TUBA4A—Cell Cycle—ZW10—bone cancer	8.08e-05	0.00117	CbGpPWpGaD
Cabazitaxel—Orthostatic hypotension—Doxorubicin—bone cancer	8.08e-05	0.00223	CcSEcCtD
Cabazitaxel—Abdominal pain upper—Doxorubicin—bone cancer	8.08e-05	0.00223	CcSEcCtD
Cabazitaxel—Hypokalaemia—Doxorubicin—bone cancer	8.05e-05	0.00222	CcSEcCtD
Cabazitaxel—TUBB2B—Metabolism of proteins—MOGS—bone cancer	7.99e-05	0.00116	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—MOGS—bone cancer	7.99e-05	0.00116	CbGpPWpGaD
Cabazitaxel—Breast disorder—Doxorubicin—bone cancer	7.99e-05	0.00221	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Doxorubicin—bone cancer	7.97e-05	0.0022	CcSEcCtD
Cabazitaxel—Decreased appetite—Cisplatin—bone cancer	7.95e-05	0.0022	CcSEcCtD
Cabazitaxel—Pneumonia—Methotrexate—bone cancer	7.92e-05	0.00219	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Cisplatin—bone cancer	7.9e-05	0.00218	CcSEcCtD
Cabazitaxel—Infestation NOS—Methotrexate—bone cancer	7.87e-05	0.00217	CcSEcCtD
Cabazitaxel—Infestation—Methotrexate—bone cancer	7.87e-05	0.00217	CcSEcCtD
Cabazitaxel—Gastritis—Doxorubicin—bone cancer	7.83e-05	0.00216	CcSEcCtD
Cabazitaxel—Pain—Cisplatin—bone cancer	7.82e-05	0.00216	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Doxorubicin—bone cancer	7.8e-05	0.00215	CcSEcCtD
Cabazitaxel—Renal failure—Methotrexate—bone cancer	7.74e-05	0.00214	CcSEcCtD
Cabazitaxel—Neutropenia—Epirubicin—bone cancer	7.73e-05	0.00213	CcSEcCtD
Cabazitaxel—Dysuria—Epirubicin—bone cancer	7.73e-05	0.00213	CcSEcCtD
Cabazitaxel—TUBB3—Metabolism of proteins—MOGS—bone cancer	7.72e-05	0.00112	CbGpPWpGaD
Cabazitaxel—Abdominal distension—Doxorubicin—bone cancer	7.7e-05	0.00213	CcSEcCtD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—ZW10—bone cancer	7.68e-05	0.00111	CbGpPWpGaD
Cabazitaxel—Upper respiratory tract infection—Epirubicin—bone cancer	7.68e-05	0.00212	CcSEcCtD
Cabazitaxel—Conjunctivitis—Methotrexate—bone cancer	7.65e-05	0.00211	CcSEcCtD
Cabazitaxel—Influenza—Doxorubicin—bone cancer	7.65e-05	0.00211	CcSEcCtD
Cabazitaxel—Pollakiuria—Epirubicin—bone cancer	7.63e-05	0.00211	CcSEcCtD
Cabazitaxel—Feeling abnormal—Cisplatin—bone cancer	7.54e-05	0.00208	CcSEcCtD
Cabazitaxel—Haematuria—Methotrexate—bone cancer	7.51e-05	0.00207	CcSEcCtD
Cabazitaxel—TUBB2A—Metabolism of proteins—MOGS—bone cancer	7.48e-05	0.00108	CbGpPWpGaD
Cabazitaxel—Weight decreased—Epirubicin—bone cancer	7.48e-05	0.00206	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Epirubicin—bone cancer	7.45e-05	0.00206	CcSEcCtD
Cabazitaxel—Pneumonia—Epirubicin—bone cancer	7.41e-05	0.00205	CcSEcCtD
Cabazitaxel—Infestation NOS—Epirubicin—bone cancer	7.37e-05	0.00203	CcSEcCtD
Cabazitaxel—Infestation—Epirubicin—bone cancer	7.37e-05	0.00203	CcSEcCtD
Cabazitaxel—TUBB1—Metabolism of proteins—MOGS—bone cancer	7.31e-05	0.00106	CbGpPWpGaD
Cabazitaxel—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	7.3e-05	0.00106	CbGpPWpGaD
Cabazitaxel—Renal failure—Epirubicin—bone cancer	7.24e-05	0.002	CcSEcCtD
Cabazitaxel—Body temperature increased—Cisplatin—bone cancer	7.23e-05	0.002	CcSEcCtD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—SPARC—bone cancer	7.23e-05	0.00105	CbGpPWpGaD
Cabazitaxel—Neuropathy peripheral—Epirubicin—bone cancer	7.22e-05	0.00199	CcSEcCtD
Cabazitaxel—Urinary tract infection—Epirubicin—bone cancer	7.16e-05	0.00198	CcSEcCtD
Cabazitaxel—Conjunctivitis—Epirubicin—bone cancer	7.16e-05	0.00198	CcSEcCtD
Cabazitaxel—Dysuria—Doxorubicin—bone cancer	7.15e-05	0.00197	CcSEcCtD
Cabazitaxel—Neutropenia—Doxorubicin—bone cancer	7.15e-05	0.00197	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Doxorubicin—bone cancer	7.11e-05	0.00196	CcSEcCtD
Cabazitaxel—Pollakiuria—Doxorubicin—bone cancer	7.06e-05	0.00195	CcSEcCtD
Cabazitaxel—Haematuria—Epirubicin—bone cancer	7.02e-05	0.00194	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Methotrexate—bone cancer	6.98e-05	0.00193	CcSEcCtD
Cabazitaxel—Urethral disorder—Methotrexate—bone cancer	6.93e-05	0.00191	CcSEcCtD
Cabazitaxel—Weight decreased—Doxorubicin—bone cancer	6.92e-05	0.00191	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Doxorubicin—bone cancer	6.9e-05	0.0019	CcSEcCtD
Cabazitaxel—TUBB—Cell Cycle—ZW10—bone cancer	6.87e-05	0.000993	CbGpPWpGaD
Cabazitaxel—Pneumonia—Doxorubicin—bone cancer	6.86e-05	0.00189	CcSEcCtD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—TUBB4B—bone cancer	6.85e-05	0.00099	CbGpPWpGaD
Cabazitaxel—Infestation NOS—Doxorubicin—bone cancer	6.82e-05	0.00188	CcSEcCtD
Cabazitaxel—Infestation—Doxorubicin—bone cancer	6.82e-05	0.00188	CcSEcCtD
Cabazitaxel—Hypersensitivity—Cisplatin—bone cancer	6.74e-05	0.00186	CcSEcCtD
Cabazitaxel—Renal failure—Doxorubicin—bone cancer	6.7e-05	0.00185	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Doxorubicin—bone cancer	6.68e-05	0.00185	CcSEcCtD
Cabazitaxel—Urinary tract infection—Doxorubicin—bone cancer	6.63e-05	0.00183	CcSEcCtD
Cabazitaxel—Conjunctivitis—Doxorubicin—bone cancer	6.63e-05	0.00183	CcSEcCtD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—GNA11—bone cancer	6.61e-05	0.000956	CbGpPWpGaD
Cabazitaxel—Eye disorder—Methotrexate—bone cancer	6.6e-05	0.00182	CcSEcCtD
Cabazitaxel—Tinnitus—Methotrexate—bone cancer	6.59e-05	0.00182	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Epirubicin—bone cancer	6.58e-05	0.00182	CcSEcCtD
Cabazitaxel—Asthenia—Cisplatin—bone cancer	6.56e-05	0.00181	CcSEcCtD
Cabazitaxel—TUBB4A—Metabolism of proteins—MOGS—bone cancer	6.56e-05	0.000949	CbGpPWpGaD
Cabazitaxel—Cardiac disorder—Methotrexate—bone cancer	6.56e-05	0.00181	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Epirubicin—bone cancer	6.53e-05	0.0018	CcSEcCtD
Cabazitaxel—Oedema peripheral—Epirubicin—bone cancer	6.52e-05	0.0018	CcSEcCtD
Cabazitaxel—Haematuria—Doxorubicin—bone cancer	6.5e-05	0.00179	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Epirubicin—bone cancer	6.5e-05	0.00179	CcSEcCtD
Cabazitaxel—Urethral disorder—Epirubicin—bone cancer	6.48e-05	0.00179	CcSEcCtD
Cabazitaxel—Angiopathy—Methotrexate—bone cancer	6.41e-05	0.00177	CcSEcCtD
Cabazitaxel—Immune system disorder—Methotrexate—bone cancer	6.38e-05	0.00176	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Methotrexate—bone cancer	6.37e-05	0.00176	CcSEcCtD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—ZW10—bone cancer	6.37e-05	0.000921	CbGpPWpGaD
Cabazitaxel—Chills—Methotrexate—bone cancer	6.34e-05	0.00175	CcSEcCtD
Cabazitaxel—Diarrhoea—Cisplatin—bone cancer	6.26e-05	0.00173	CcSEcCtD
Cabazitaxel—Alopecia—Methotrexate—bone cancer	6.25e-05	0.00172	CcSEcCtD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—RFC1—bone cancer	6.21e-05	0.000898	CbGpPWpGaD
Cabazitaxel—Mental disorder—Methotrexate—bone cancer	6.19e-05	0.00171	CcSEcCtD
Cabazitaxel—Eye disorder—Epirubicin—bone cancer	6.18e-05	0.00171	CcSEcCtD
Cabazitaxel—Tinnitus—Epirubicin—bone cancer	6.17e-05	0.0017	CcSEcCtD
Cabazitaxel—Erythema—Methotrexate—bone cancer	6.15e-05	0.0017	CcSEcCtD
Cabazitaxel—Malnutrition—Methotrexate—bone cancer	6.15e-05	0.0017	CcSEcCtD
Cabazitaxel—Flushing—Epirubicin—bone cancer	6.14e-05	0.0017	CcSEcCtD
Cabazitaxel—Cardiac disorder—Epirubicin—bone cancer	6.14e-05	0.0017	CcSEcCtD
Cabazitaxel—TUBA4A—Cell Cycle—TUBB4B—bone cancer	6.12e-05	0.000885	CbGpPWpGaD
Cabazitaxel—Hypoaesthesia—Doxorubicin—bone cancer	6.09e-05	0.00168	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Doxorubicin—bone cancer	6.04e-05	0.00167	CcSEcCtD
Cabazitaxel—Oedema peripheral—Doxorubicin—bone cancer	6.03e-05	0.00166	CcSEcCtD
Cabazitaxel—Dysgeusia—Methotrexate—bone cancer	6.02e-05	0.00166	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Doxorubicin—bone cancer	6.01e-05	0.00166	CcSEcCtD
Cabazitaxel—TUBB4B—Metabolism of proteins—MOGS—bone cancer	6e-05	0.000868	CbGpPWpGaD
Cabazitaxel—Angiopathy—Epirubicin—bone cancer	6e-05	0.00166	CcSEcCtD
Cabazitaxel—Urethral disorder—Doxorubicin—bone cancer	6e-05	0.00166	CcSEcCtD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—IL3—bone cancer	6e-05	0.000867	CbGpPWpGaD
Cabazitaxel—Immune system disorder—Epirubicin—bone cancer	5.97e-05	0.00165	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Epirubicin—bone cancer	5.96e-05	0.00165	CcSEcCtD
Cabazitaxel—Back pain—Methotrexate—bone cancer	5.95e-05	0.00164	CcSEcCtD
Cabazitaxel—Chills—Epirubicin—bone cancer	5.93e-05	0.00164	CcSEcCtD
Cabazitaxel—Arrhythmia—Epirubicin—bone cancer	5.91e-05	0.00163	CcSEcCtD
Cabazitaxel—Alopecia—Epirubicin—bone cancer	5.84e-05	0.00161	CcSEcCtD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—ZW10—bone cancer	5.82e-05	0.000842	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—TUBB4B—bone cancer	5.82e-05	0.000842	CbGpPWpGaD
Cabazitaxel—Vomiting—Cisplatin—bone cancer	5.82e-05	0.00161	CcSEcCtD
Cabazitaxel—Mental disorder—Epirubicin—bone cancer	5.79e-05	0.0016	CcSEcCtD
Cabazitaxel—Erythema—Epirubicin—bone cancer	5.76e-05	0.00159	CcSEcCtD
Cabazitaxel—Malnutrition—Epirubicin—bone cancer	5.76e-05	0.00159	CcSEcCtD
Cabazitaxel—Eye disorder—Doxorubicin—bone cancer	5.72e-05	0.00158	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Methotrexate—bone cancer	5.71e-05	0.00158	CcSEcCtD
Cabazitaxel—Tinnitus—Doxorubicin—bone cancer	5.71e-05	0.00158	CcSEcCtD
Cabazitaxel—TUBB4A—Cell Cycle—ZW10—bone cancer	5.69e-05	0.000823	CbGpPWpGaD
Cabazitaxel—Anaemia—Methotrexate—bone cancer	5.69e-05	0.00157	CcSEcCtD
Cabazitaxel—Flushing—Doxorubicin—bone cancer	5.68e-05	0.00157	CcSEcCtD
Cabazitaxel—Cardiac disorder—Doxorubicin—bone cancer	5.68e-05	0.00157	CcSEcCtD
Cabazitaxel—Dysgeusia—Epirubicin—bone cancer	5.64e-05	0.00156	CcSEcCtD
Cabazitaxel—Back pain—Epirubicin—bone cancer	5.57e-05	0.00154	CcSEcCtD
Cabazitaxel—TUBA4A—Cell Cycle—RFC1—bone cancer	5.55e-05	0.000803	CbGpPWpGaD
Cabazitaxel—Angiopathy—Doxorubicin—bone cancer	5.55e-05	0.00153	CcSEcCtD
Cabazitaxel—Malaise—Methotrexate—bone cancer	5.55e-05	0.00153	CcSEcCtD
Cabazitaxel—Muscle spasms—Epirubicin—bone cancer	5.54e-05	0.00153	CcSEcCtD
Cabazitaxel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	5.54e-05	0.0008	CbGpPWpGaD
Cabazitaxel—Immune system disorder—Doxorubicin—bone cancer	5.53e-05	0.00153	CcSEcCtD
Cabazitaxel—Vertigo—Methotrexate—bone cancer	5.53e-05	0.00153	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Doxorubicin—bone cancer	5.52e-05	0.00152	CcSEcCtD
Cabazitaxel—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	5.51e-05	0.000797	CbGpPWpGaD
Cabazitaxel—Leukopenia—Methotrexate—bone cancer	5.51e-05	0.00152	CcSEcCtD
Cabazitaxel—Chills—Doxorubicin—bone cancer	5.49e-05	0.00152	CcSEcCtD
Cabazitaxel—Arrhythmia—Doxorubicin—bone cancer	5.47e-05	0.00151	CcSEcCtD
Cabazitaxel—Nausea—Cisplatin—bone cancer	5.43e-05	0.0015	CcSEcCtD
Cabazitaxel—Alopecia—Doxorubicin—bone cancer	5.41e-05	0.00149	CcSEcCtD
Cabazitaxel—Cough—Methotrexate—bone cancer	5.37e-05	0.00148	CcSEcCtD
Cabazitaxel—Mental disorder—Doxorubicin—bone cancer	5.36e-05	0.00148	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Epirubicin—bone cancer	5.34e-05	0.00148	CcSEcCtD
Cabazitaxel—Erythema—Doxorubicin—bone cancer	5.33e-05	0.00147	CcSEcCtD
Cabazitaxel—Malnutrition—Doxorubicin—bone cancer	5.33e-05	0.00147	CcSEcCtD
Cabazitaxel—Anaemia—Epirubicin—bone cancer	5.32e-05	0.00147	CcSEcCtD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—RFC1—bone cancer	5.28e-05	0.000763	CbGpPWpGaD
Cabazitaxel—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	5.25e-05	0.000759	CbGpPWpGaD
Cabazitaxel—Myalgia—Methotrexate—bone cancer	5.24e-05	0.00145	CcSEcCtD
Cabazitaxel—Arthralgia—Methotrexate—bone cancer	5.24e-05	0.00145	CcSEcCtD
Cabazitaxel—Chest pain—Methotrexate—bone cancer	5.24e-05	0.00145	CcSEcCtD
Cabazitaxel—Dysgeusia—Doxorubicin—bone cancer	5.22e-05	0.00144	CcSEcCtD
Cabazitaxel—TUBB—Cell Cycle—TUBB4B—bone cancer	5.21e-05	0.000753	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—ZW10—bone cancer	5.21e-05	0.000753	CbGpPWpGaD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	5.2e-05	0.00144	CcSEcCtD
Cabazitaxel—Malaise—Epirubicin—bone cancer	5.19e-05	0.00143	CcSEcCtD
Cabazitaxel—Discomfort—Methotrexate—bone cancer	5.17e-05	0.00143	CcSEcCtD
Cabazitaxel—Vertigo—Epirubicin—bone cancer	5.17e-05	0.00143	CcSEcCtD
Cabazitaxel—Leukopenia—Epirubicin—bone cancer	5.15e-05	0.00142	CcSEcCtD
Cabazitaxel—Back pain—Doxorubicin—bone cancer	5.15e-05	0.00142	CcSEcCtD
Cabazitaxel—Muscle spasms—Doxorubicin—bone cancer	5.12e-05	0.00141	CcSEcCtD
Cabazitaxel—TUBA4A—Metabolism of proteins—TUBB4B—bone cancer	5.11e-05	0.000738	CbGpPWpGaD
Cabazitaxel—TUBB2A—Signaling events mediated by HDAC Class III—TP53—bone cancer	5.08e-05	0.000735	CbGpPWpGaD
Cabazitaxel—Confusional state—Methotrexate—bone cancer	5.06e-05	0.0014	CcSEcCtD
Cabazitaxel—Cough—Epirubicin—bone cancer	5.02e-05	0.00139	CcSEcCtD
Cabazitaxel—Infection—Methotrexate—bone cancer	4.99e-05	0.00138	CcSEcCtD
Cabazitaxel—Hypertension—Epirubicin—bone cancer	4.97e-05	0.00137	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Doxorubicin—bone cancer	4.94e-05	0.00136	CcSEcCtD
Cabazitaxel—Nervous system disorder—Methotrexate—bone cancer	4.92e-05	0.00136	CcSEcCtD
Cabazitaxel—Anaemia—Doxorubicin—bone cancer	4.92e-05	0.00136	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Methotrexate—bone cancer	4.92e-05	0.00136	CcSEcCtD
Cabazitaxel—Myalgia—Epirubicin—bone cancer	4.9e-05	0.00135	CcSEcCtD
Cabazitaxel—Chest pain—Epirubicin—bone cancer	4.9e-05	0.00135	CcSEcCtD
Cabazitaxel—Arthralgia—Epirubicin—bone cancer	4.9e-05	0.00135	CcSEcCtD
Cabazitaxel—Anxiety—Epirubicin—bone cancer	4.88e-05	0.00135	CcSEcCtD
Cabazitaxel—Skin disorder—Methotrexate—bone cancer	4.88e-05	0.00135	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	4.87e-05	0.00134	CcSEcCtD
Cabazitaxel—Discomfort—Epirubicin—bone cancer	4.84e-05	0.00134	CcSEcCtD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—TUBB4B—bone cancer	4.83e-05	0.000698	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.82e-05	0.000697	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.82e-05	0.000697	CbGpPWpGaD
Cabazitaxel—Malaise—Doxorubicin—bone cancer	4.8e-05	0.00133	CcSEcCtD
Cabazitaxel—Dry mouth—Epirubicin—bone cancer	4.79e-05	0.00132	CcSEcCtD
Cabazitaxel—Vertigo—Doxorubicin—bone cancer	4.79e-05	0.00132	CcSEcCtD
Cabazitaxel—Anorexia—Methotrexate—bone cancer	4.79e-05	0.00132	CcSEcCtD
Cabazitaxel—Leukopenia—Doxorubicin—bone cancer	4.77e-05	0.00132	CcSEcCtD
Cabazitaxel—Confusional state—Epirubicin—bone cancer	4.74e-05	0.00131	CcSEcCtD
Cabazitaxel—TUBB—Cell Cycle—RFC1—bone cancer	4.72e-05	0.000683	CbGpPWpGaD
Cabazitaxel—Oedema—Epirubicin—bone cancer	4.7e-05	0.0013	CcSEcCtD
Cabazitaxel—Hypotension—Methotrexate—bone cancer	4.69e-05	0.0013	CcSEcCtD
Cabazitaxel—Infection—Epirubicin—bone cancer	4.67e-05	0.00129	CcSEcCtD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.66e-05	0.000673	CbGpPWpGaD
Cabazitaxel—Cough—Doxorubicin—bone cancer	4.65e-05	0.00128	CcSEcCtD
Cabazitaxel—Nervous system disorder—Epirubicin—bone cancer	4.61e-05	0.00127	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Epirubicin—bone cancer	4.6e-05	0.00127	CcSEcCtD
Cabazitaxel—Hypertension—Doxorubicin—bone cancer	4.6e-05	0.00127	CcSEcCtD
Cabazitaxel—Tachycardia—Epirubicin—bone cancer	4.59e-05	0.00127	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Methotrexate—bone cancer	4.57e-05	0.00126	CcSEcCtD
Cabazitaxel—Skin disorder—Epirubicin—bone cancer	4.56e-05	0.00126	CcSEcCtD
Cabazitaxel—Myalgia—Doxorubicin—bone cancer	4.54e-05	0.00125	CcSEcCtD
Cabazitaxel—Arthralgia—Doxorubicin—bone cancer	4.54e-05	0.00125	CcSEcCtD
Cabazitaxel—Chest pain—Doxorubicin—bone cancer	4.54e-05	0.00125	CcSEcCtD
Cabazitaxel—Anxiety—Doxorubicin—bone cancer	4.52e-05	0.00125	CcSEcCtD
Cabazitaxel—Paraesthesia—Methotrexate—bone cancer	4.51e-05	0.00125	CcSEcCtD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.51e-05	0.000652	CbGpPWpGaD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	4.5e-05	0.00124	CcSEcCtD
Cabazitaxel—Discomfort—Doxorubicin—bone cancer	4.48e-05	0.00124	CcSEcCtD
Cabazitaxel—Anorexia—Epirubicin—bone cancer	4.48e-05	0.00124	CcSEcCtD
Cabazitaxel—Dyspnoea—Methotrexate—bone cancer	4.48e-05	0.00124	CcSEcCtD
Cabazitaxel—Dry mouth—Doxorubicin—bone cancer	4.44e-05	0.00122	CcSEcCtD
Cabazitaxel—Dyspepsia—Methotrexate—bone cancer	4.42e-05	0.00122	CcSEcCtD
Cabazitaxel—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	4.42e-05	0.000638	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	4.41e-05	0.000637	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	4.41e-05	0.000637	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—TUBB2A—bone cancer	4.41e-05	0.000637	CbGpPWpGaD
Cabazitaxel—Hypotension—Epirubicin—bone cancer	4.39e-05	0.00121	CcSEcCtD
Cabazitaxel—Confusional state—Doxorubicin—bone cancer	4.38e-05	0.00121	CcSEcCtD
Cabazitaxel—TUBB2B—Metabolism of proteins—TUBB4B—bone cancer	4.38e-05	0.000633	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—TUBB4B—bone cancer	4.38e-05	0.000633	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—RFC1—bone cancer	4.38e-05	0.000633	CbGpPWpGaD
Cabazitaxel—Decreased appetite—Methotrexate—bone cancer	4.36e-05	0.00121	CcSEcCtD
Cabazitaxel—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	4.36e-05	0.00063	CbGpPWpGaD
Cabazitaxel—Oedema—Doxorubicin—bone cancer	4.35e-05	0.0012	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Methotrexate—bone cancer	4.33e-05	0.0012	CcSEcCtD
Cabazitaxel—Fatigue—Methotrexate—bone cancer	4.33e-05	0.0012	CcSEcCtD
Cabazitaxel—Infection—Doxorubicin—bone cancer	4.32e-05	0.00119	CcSEcCtD
Cabazitaxel—TUBB4A—Cell Cycle—TUBB4B—bone cancer	4.32e-05	0.000624	CbGpPWpGaD
Cabazitaxel—Pain—Methotrexate—bone cancer	4.29e-05	0.00119	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Epirubicin—bone cancer	4.28e-05	0.00118	CcSEcCtD
Cabazitaxel—Nervous system disorder—Doxorubicin—bone cancer	4.26e-05	0.00118	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Doxorubicin—bone cancer	4.26e-05	0.00118	CcSEcCtD
Cabazitaxel—Tachycardia—Doxorubicin—bone cancer	4.24e-05	0.00117	CcSEcCtD
Cabazitaxel—TUBB3—Metabolism of proteins—TUBB4B—bone cancer	4.23e-05	0.000612	CbGpPWpGaD
Cabazitaxel—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	4.23e-05	0.000611	CbGpPWpGaD
Cabazitaxel—Skin disorder—Doxorubicin—bone cancer	4.22e-05	0.00117	CcSEcCtD
Cabazitaxel—Paraesthesia—Epirubicin—bone cancer	4.22e-05	0.00117	CcSEcCtD
Cabazitaxel—Dyspnoea—Epirubicin—bone cancer	4.19e-05	0.00116	CcSEcCtD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.16e-05	0.000602	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.16e-05	0.000602	CbGpPWpGaD
Cabazitaxel—Anorexia—Doxorubicin—bone cancer	4.14e-05	0.00114	CcSEcCtD
Cabazitaxel—Feeling abnormal—Methotrexate—bone cancer	4.14e-05	0.00114	CcSEcCtD
Cabazitaxel—Dyspepsia—Epirubicin—bone cancer	4.14e-05	0.00114	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Methotrexate—bone cancer	4.11e-05	0.00113	CcSEcCtD
Cabazitaxel—TUBB2A—Metabolism of proteins—TUBB4B—bone cancer	4.1e-05	0.000592	CbGpPWpGaD
Cabazitaxel—Decreased appetite—Epirubicin—bone cancer	4.08e-05	0.00113	CcSEcCtD
Cabazitaxel—Hypotension—Doxorubicin—bone cancer	4.06e-05	0.00112	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Epirubicin—bone cancer	4.06e-05	0.00112	CcSEcCtD
Cabazitaxel—Fatigue—Epirubicin—bone cancer	4.05e-05	0.00112	CcSEcCtD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.02e-05	0.000581	CbGpPWpGaD
Cabazitaxel—Constipation—Epirubicin—bone cancer	4.02e-05	0.00111	CcSEcCtD
Cabazitaxel—Pain—Epirubicin—bone cancer	4.02e-05	0.00111	CcSEcCtD
Cabazitaxel—TUBB1—Metabolism of proteins—TUBB4B—bone cancer	4.01e-05	0.000579	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—RFC1—bone cancer	4e-05	0.000579	CbGpPWpGaD
Cabazitaxel—Abdominal pain—Methotrexate—bone cancer	3.97e-05	0.0011	CcSEcCtD
Cabazitaxel—Body temperature increased—Methotrexate—bone cancer	3.97e-05	0.0011	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Doxorubicin—bone cancer	3.96e-05	0.00109	CcSEcCtD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.96e-05	0.000572	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—RFC1—bone cancer	3.91e-05	0.000566	CbGpPWpGaD
Cabazitaxel—Paraesthesia—Doxorubicin—bone cancer	3.9e-05	0.00108	CcSEcCtD
Cabazitaxel—Dyspnoea—Doxorubicin—bone cancer	3.88e-05	0.00107	CcSEcCtD
Cabazitaxel—Feeling abnormal—Epirubicin—bone cancer	3.87e-05	0.00107	CcSEcCtD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—DHFR—bone cancer	3.85e-05	0.000557	CbGpPWpGaD
Cabazitaxel—Gastrointestinal pain—Epirubicin—bone cancer	3.84e-05	0.00106	CcSEcCtD
Cabazitaxel—Dyspepsia—Doxorubicin—bone cancer	3.83e-05	0.00106	CcSEcCtD
Cabazitaxel—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	3.82e-05	0.000553	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.81e-05	0.00055	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—TUBB2A—bone cancer	3.78e-05	0.000547	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—TUBB2A—bone cancer	3.78e-05	0.000547	CbGpPWpGaD
Cabazitaxel—Decreased appetite—Doxorubicin—bone cancer	3.78e-05	0.00104	CcSEcCtD
Cabazitaxel—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	3.77e-05	0.000546	CbGpPWpGaD
Cabazitaxel—Gastrointestinal disorder—Doxorubicin—bone cancer	3.75e-05	0.00104	CcSEcCtD
Cabazitaxel—Fatigue—Doxorubicin—bone cancer	3.75e-05	0.00104	CcSEcCtD
Cabazitaxel—TUBA4A—Hemostasis—SPARC—bone cancer	3.73e-05	0.000539	CbGpPWpGaD
Cabazitaxel—Pain—Doxorubicin—bone cancer	3.72e-05	0.00103	CcSEcCtD
Cabazitaxel—Constipation—Doxorubicin—bone cancer	3.72e-05	0.00103	CcSEcCtD
Cabazitaxel—Body temperature increased—Epirubicin—bone cancer	3.71e-05	0.00103	CcSEcCtD
Cabazitaxel—Abdominal pain—Epirubicin—bone cancer	3.71e-05	0.00103	CcSEcCtD
Cabazitaxel—Hypersensitivity—Methotrexate—bone cancer	3.7e-05	0.00102	CcSEcCtD
Cabazitaxel—TUBB3—Metabolism of proteins—TUBB2A—bone cancer	3.65e-05	0.000528	CbGpPWpGaD
Cabazitaxel—Asthenia—Methotrexate—bone cancer	3.6e-05	0.000995	CcSEcCtD
Cabazitaxel—TUBB4A—Metabolism of proteins—TUBB4B—bone cancer	3.6e-05	0.00052	CbGpPWpGaD
Cabazitaxel—Feeling abnormal—Doxorubicin—bone cancer	3.58e-05	0.000989	CcSEcCtD
Cabazitaxel—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	3.58e-05	0.000518	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—RFC1—bone cancer	3.58e-05	0.000517	CbGpPWpGaD
Cabazitaxel—Gastrointestinal pain—Doxorubicin—bone cancer	3.56e-05	0.000982	CcSEcCtD
Cabazitaxel—Hypersensitivity—Epirubicin—bone cancer	3.46e-05	0.000956	CcSEcCtD
Cabazitaxel—TUBB1—Metabolism of proteins—TUBB2A—bone cancer	3.46e-05	0.0005	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—DHFR—bone cancer	3.44e-05	0.000498	CbGpPWpGaD
Cabazitaxel—Body temperature increased—Doxorubicin—bone cancer	3.44e-05	0.000949	CcSEcCtD
Cabazitaxel—Abdominal pain—Doxorubicin—bone cancer	3.44e-05	0.000949	CcSEcCtD
Cabazitaxel—Diarrhoea—Methotrexate—bone cancer	3.44e-05	0.000949	CcSEcCtD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.42e-05	0.000494	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—GNA11—bone cancer	3.41e-05	0.000493	CbGpPWpGaD
Cabazitaxel—Asthenia—Epirubicin—bone cancer	3.37e-05	0.000931	CcSEcCtD
Cabazitaxel—Dizziness—Methotrexate—bone cancer	3.32e-05	0.000917	CcSEcCtD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—DHFR—bone cancer	3.27e-05	0.000473	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.27e-05	0.000473	CbGpPWpGaD
Cabazitaxel—Diarrhoea—Epirubicin—bone cancer	3.21e-05	0.000888	CcSEcCtD
Cabazitaxel—Hypersensitivity—Doxorubicin—bone cancer	3.2e-05	0.000885	CcSEcCtD
Cabazitaxel—Vomiting—Methotrexate—bone cancer	3.19e-05	0.000882	CcSEcCtD
Cabazitaxel—Headache—Methotrexate—bone cancer	3.15e-05	0.000869	CcSEcCtD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.12e-05	0.000452	CbGpPWpGaD
Cabazitaxel—Asthenia—Doxorubicin—bone cancer	3.12e-05	0.000861	CcSEcCtD
Cabazitaxel—Dizziness—Epirubicin—bone cancer	3.11e-05	0.000858	CcSEcCtD
Cabazitaxel—TUBB4A—Metabolism of proteins—TUBB2A—bone cancer	3.1e-05	0.000449	CbGpPWpGaD
Cabazitaxel—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	3.1e-05	0.000448	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—IL3—bone cancer	3.09e-05	0.000447	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—EIF2S1—bone cancer	3.07e-05	0.000444	CbGpPWpGaD
Cabazitaxel—Vomiting—Epirubicin—bone cancer	2.99e-05	0.000825	CcSEcCtD
Cabazitaxel—Nausea—Methotrexate—bone cancer	2.98e-05	0.000824	CcSEcCtD
Cabazitaxel—Diarrhoea—Doxorubicin—bone cancer	2.97e-05	0.000821	CcSEcCtD
Cabazitaxel—Headache—Epirubicin—bone cancer	2.94e-05	0.000813	CcSEcCtD
Cabazitaxel—TUBB—Cell Cycle—DHFR—bone cancer	2.93e-05	0.000423	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—CHEK2—bone cancer	2.88e-05	0.000416	CbGpPWpGaD
Cabazitaxel—Dizziness—Doxorubicin—bone cancer	2.88e-05	0.000794	CcSEcCtD
Cabazitaxel—TUBB4B—Metabolism of proteins—TUBB2A—bone cancer	2.84e-05	0.000411	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—TUBB2A—bone cancer	2.82e-05	0.000408	CbGpPWpGaD
Cabazitaxel—Nausea—Epirubicin—bone cancer	2.79e-05	0.000771	CcSEcCtD
Cabazitaxel—Vomiting—Doxorubicin—bone cancer	2.76e-05	0.000763	CcSEcCtD
Cabazitaxel—Headache—Doxorubicin—bone cancer	2.72e-05	0.000752	CcSEcCtD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—DHFR—bone cancer	2.71e-05	0.000392	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—EIF2S1—bone cancer	2.64e-05	0.000381	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—EIF2S1—bone cancer	2.64e-05	0.000381	CbGpPWpGaD
Cabazitaxel—ABCG2—Fluoropyrimidine Activity—TP53—bone cancer	2.62e-05	0.000379	CbGpPWpGaD
Cabazitaxel—Nausea—Doxorubicin—bone cancer	2.58e-05	0.000713	CcSEcCtD
Cabazitaxel—SLCO1B3—Metabolism—NDUFA12—bone cancer	2.56e-05	0.00037	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—EIF2S1—bone cancer	2.55e-05	0.000368	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—DHFR—bone cancer	2.48e-05	0.000359	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—EIF2S1—bone cancer	2.47e-05	0.000357	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—CHEK2—bone cancer	2.45e-05	0.000354	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—BRCA2—bone cancer	2.44e-05	0.000353	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—DHFR—bone cancer	2.43e-05	0.000351	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—EIF2S1—bone cancer	2.41e-05	0.000349	CbGpPWpGaD
Cabazitaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	2.29e-05	0.000331	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—JUN—bone cancer	2.28e-05	0.00033	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—DHFR—bone cancer	2.22e-05	0.000321	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—TUBB4B—bone cancer	2.2e-05	0.000318	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—EIF2S1—bone cancer	2.17e-05	0.000313	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—NT5C3A—bone cancer	2.12e-05	0.000306	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—BRCA2—bone cancer	2.07e-05	0.0003	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	2.03e-05	0.000294	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—PLAU—bone cancer	2.03e-05	0.000293	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CHEK2—bone cancer	2.03e-05	0.000293	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—CDK4—bone cancer	2.02e-05	0.000292	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—EIF2S1—bone cancer	1.98e-05	0.000286	CbGpPWpGaD
Cabazitaxel—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	1.96e-05	0.000283	CbGpPWpGaD
Cabazitaxel—CYP3A5—Biological oxidations—CYP3A4—bone cancer	1.9e-05	0.000275	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.9e-05	0.000274	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	1.88e-05	0.000271	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	1.87e-05	0.000271	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CHEK2—bone cancer	1.85e-05	0.000268	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—CDK4—bone cancer	1.81e-05	0.000261	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—RB1—bone cancer	1.76e-05	0.000254	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	1.76e-05	0.000254	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—CDK4—bone cancer	1.72e-05	0.000249	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—NDUFA12—bone cancer	1.72e-05	0.000248	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—BRCA2—bone cancer	1.72e-05	0.000248	CbGpPWpGaD
Cabazitaxel—CYP2C8—Biological oxidations—CYP3A4—bone cancer	1.65e-05	0.000238	CbGpPWpGaD
Cabazitaxel—CYP3A5—Biological oxidations—GSTP1—bone cancer	1.63e-05	0.000235	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	1.62e-05	0.000235	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	1.6e-05	0.000232	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	1.59e-05	0.00023	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—NDUFA12—bone cancer	1.59e-05	0.00023	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—RB1—bone cancer	1.57e-05	0.000227	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—BRCA2—bone cancer	1.57e-05	0.000227	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—CDK4—bone cancer	1.54e-05	0.000222	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—RB1—bone cancer	1.5e-05	0.000216	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	1.45e-05	0.000209	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—CDK4—bone cancer	1.42e-05	0.000206	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—NT5C3A—bone cancer	1.42e-05	0.000206	CbGpPWpGaD
Cabazitaxel—CYP2C8—Biological oxidations—GSTP1—bone cancer	1.41e-05	0.000204	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	1.39e-05	0.000201	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—MDM2—bone cancer	1.34e-05	0.000194	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—RB1—bone cancer	1.34e-05	0.000193	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	1.32e-05	0.000191	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—NT5C3A—bone cancer	1.32e-05	0.000191	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—CDK4—bone cancer	1.3e-05	0.000188	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	1.3e-05	0.000188	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CDK4—bone cancer	1.27e-05	0.000184	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—MMP2—bone cancer	1.26e-05	0.000182	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—RB1—bone cancer	1.24e-05	0.000179	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	1.23e-05	0.000178	CbGpPWpGaD
Cabazitaxel—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	1.17e-05	0.000169	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CDK4—bone cancer	1.17e-05	0.000168	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—MDM2—bone cancer	1.14e-05	0.000165	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NDUFA12—bone cancer	1.14e-05	0.000165	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—RB1—bone cancer	1.13e-05	0.000164	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—RB1—bone cancer	1.11e-05	0.00016	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	1.1e-05	0.000159	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	1.1e-05	0.000159	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—MMP2—bone cancer	1.08e-05	0.000156	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—MMP2—bone cancer	1.08e-05	0.000156	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—MMP2—bone cancer	1.04e-05	0.000151	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—RB1—bone cancer	1.01e-05	0.000146	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—MMP2—bone cancer	1.01e-05	0.000146	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NDUFA12—bone cancer	9.87e-06	0.000143	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—MMP2—bone cancer	9.87e-06	0.000143	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	9.5e-06	0.000137	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—MDM2—bone cancer	9.45e-06	0.000137	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NT5C3A—bone cancer	9.44e-06	0.000137	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—ENO2—bone cancer	9.28e-06	0.000134	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—MMP2—bone cancer	8.86e-06	0.000128	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—MDM2—bone cancer	8.64e-06	0.000125	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—DHFR—bone cancer	8.61e-06	0.000124	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NDUFA12—bone cancer	8.6e-06	0.000124	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	8.18e-06	0.000118	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NT5C3A—bone cancer	8.18e-06	0.000118	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—TP53—bone cancer	8.15e-06	0.000118	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—MMP2—bone cancer	8.1e-06	0.000117	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GNA11—bone cancer	8.05e-06	0.000116	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—TP53—bone cancer	7.69e-06	0.000111	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—GSTP1—bone cancer	7.56e-06	0.000109	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	7.46e-06	0.000108	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CYP3A4—bone cancer	7.3e-06	0.000105	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.26e-06	0.000105	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NT5C3A—bone cancer	7.13e-06	0.000103	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—TP53—bone cancer	6.54e-06	9.46e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GSTP1—bone cancer	6.24e-06	9.02e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ENO2—bone cancer	6.24e-06	9.02e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	6.06e-06	8.77e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	5.85e-06	8.45e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—DHFR—bone cancer	5.78e-06	8.36e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ENO2—bone cancer	5.77e-06	8.35e-05	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—TP53—bone cancer	5.42e-06	7.84e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GNA11—bone cancer	5.41e-06	7.82e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—DHFR—bone cancer	5.36e-06	7.74e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NDUFA12—bone cancer	5.3e-06	7.66e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	5.27e-06	7.62e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GNA11—bone cancer	5.01e-06	7.24e-05	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TP53—bone cancer	4.96e-06	7.17e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CYP3A4—bone cancer	4.9e-06	7.09e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	4.88e-06	7.05e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYP3A4—bone cancer	4.54e-06	6.56e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NT5C3A—bone cancer	4.39e-06	6.35e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GSTP1—bone cancer	4.19e-06	6.06e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	4.14e-06	5.99e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ENO2—bone cancer	4.14e-06	5.98e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GSTP1—bone cancer	3.88e-06	5.61e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—DHFR—bone cancer	3.84e-06	5.55e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GNA11—bone cancer	3.59e-06	5.19e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ENO2—bone cancer	3.58e-06	5.18e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	3.48e-06	5.03e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—DHFR—bone cancer	3.32e-06	4.81e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP3A4—bone cancer	3.25e-06	4.7e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTGS2—bone cancer	3.23e-06	4.67e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ENO2—bone cancer	3.12e-06	4.51e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GNA11—bone cancer	3.11e-06	4.49e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—DHFR—bone cancer	2.9e-06	4.19e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP3A4—bone cancer	2.82e-06	4.07e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.8e-06	4.05e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTP1—bone cancer	2.78e-06	4.02e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GNA11—bone cancer	2.71e-06	3.91e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP3A4—bone cancer	2.45e-06	3.55e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTP1—bone cancer	2.41e-06	3.48e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTGS2—bone cancer	2.17e-06	3.14e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTP1—bone cancer	2.1e-06	3.03e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTGS2—bone cancer	2.01e-06	2.91e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ENO2—bone cancer	1.92e-06	2.78e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—DHFR—bone cancer	1.78e-06	2.58e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GNA11—bone cancer	1.67e-06	2.41e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTGS2—bone cancer	1.44e-06	2.08e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTP1—bone cancer	1.29e-06	1.87e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTGS2—bone cancer	1.25e-06	1.8e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTGS2—bone cancer	1.09e-06	1.57e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTGS2—bone cancer	6.7e-07	9.68e-06	CbGpPWpGaD
